Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2026-03-03 @ 6:16 AM
Study NCT ID:
NCT00983528
Status:
TERMINATED
Last Update Posted:
2020-08-12
First Post:
2009-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia
Sponsor:
Organization: